Our data confirmed previous observations made in glioma samples classified according to the 2007 WHO criteria (i.e., GBM and lower-grade glioma) that HOXA-AS2 is upregulated in glioma and that its expression level is positively associated with advanced tumor stages [25,26]. The gene discussed is HOXA-AS2; the disease is glioblastoma.